Table 2.
One-Year Follow-Up of Patients with Post-COVID-19 Condition and Pulmonary Embolism (n=5)
| Parameter | Median (Range) | Normal Range |
|---|---|---|
| Hematology | ||
| White blood cell count (/μL) | 6480 (3640–9400) | 4000–11000 |
| Hemoglobin (g/dL) | 13.0 (12.7–15.6) | 12–16 |
| Platelet (103/μL) | 262 (172–348) | 150–450 |
| Inflammation markers | ||
| C-reactive protein (mg/dL) | 0.1 (0.1–0.8) | < 0.5 |
| Procalcitonin (ng/mL) | 0.03 (0.02–0.37) | < 0.5 |
| Liver function | ||
| Alanine aminotransferase (U/L) | 18 (13–43) | 0–50 |
| Aspartate aminotransferase (U/L) | 16 (13–44) | 0–50 |
| Total bilirubin (mg/dL) | 0.64 (0.40–0.91) | 0.3–1.2 |
| Kidney function | ||
| Creatinine (mg/dL) | 0.72 (0.58–1.22) | 0.6–1.3 |
| Cardiac markers | ||
| Creatine kinase (U/L) | 90 (48–110) | 30–200 |
| Troponin-T (ng/L) | 3.77 (3.21–10.68) | < 14 |
| Coagulation | ||
| D-dimer (mg/L FEU) | 0.38 (0.23–1.03) | < 0.5 |
| Imaging results | n (%) | |
| No active lung lesion on chest X-ray | 5 (100%) | |
| Sinus rhythm on ECG | 5 (100%) | |
| Quality of life measures | Mean ± SD (Range) | |
| EQ-5D-5L index | 0.928 ± 0.119 (0.7261–1.0000) | |
| EQ-VAS | 85.00 ± 11.18 (70–100) |
Abbreviations: ECG, Electrocardiogram; EQ-5D-5L, EuroQoL 5-Dimension 5-Level; EQ-VAS, EuroQoL Visual Analogue Scale; FEU, Fibrinogen Equivalent Units; SD, Standard Deviation.